SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bafna Pharmaceuticals informs about financial results

21 May 2013 Evaluate

Bafna Pharmaceuticals has informed about the financial results & a copy of the Auditors Report for the period ended March 31, 2013.

The above information is a part of company’s filings submitted to BSE.

Bafna Pharma Share Price

137.75 -7.25 (-5.00%)
13-Apr-2026 10:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1647.40
Dr. Reddys Lab 1220.20
Cipla 1213.20
Zydus Lifesciences 923.65
Lupin 2329.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×